HWAM
Hennion & Walsh Asset Management’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Sell |
3,530
-1,512
| -30% | -$132K | 0.01% | 799 |
|
|
2025
Q1 | $344K | Sell |
5,042
-121
| -2% | -$8.26K | 0.02% | 735 |
|
|
2024
Q4 | $402K | Buy |
5,163
+754
| +17% | +$58.6K | 0.02% | 689 |
|
|
2024
Q3 | $296K | Buy |
4,409
+579
| +15% | +$38.8K | 0.01% | 740 |
|
|
2024
Q2 | $434K | Buy |
3,830
+2,203
| +135% | +$250K | 0.02% | 630 |
|
|
2024
Q1 | $226K | Sell |
1,627
-45
| -3% | -$6.24K | 0.01% | 770 |
|
|
2023
Q4 | $207K | Buy |
+1,672
| New | +$207K | 0.01% | 767 |
|
|
2022
Q4 | – | Sell |
-4,135
| Closed | -$333K | – | 776 |
|
|
2022
Q3 | $333K | Sell |
4,135
-103
| -2% | -$8.3K | 0.02% | 576 |
|
|
2022
Q2 | $316K | Buy |
4,238
+3,118
| +278% | +$232K | 0.02% | 616 |
|
|
2022
Q1 | $573K | Buy |
1,120
+32
| +3% | +$16.4K | 0.03% | 485 |
|
|
2021
Q4 | $584K | Sell |
1,088
-10
| -0.9% | -$5.37K | 0.03% | 505 |
|
|
2021
Q3 | $600K | Sell |
1,098
-17
| -2% | -$9.29K | 0.03% | 468 |
|
|
2021
Q2 | $476K | Buy |
1,115
+162
| +17% | +$69.2K | 0.03% | 535 |
|
|
2021
Q1 | $342K | Buy |
+953
| New | +$342K | 0.02% | 567 |
|